Virus cocktail fights deadly heart infection in new trial
NCT ID NCT06870409
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a special virus mixture (phage therapy) to standard antibiotics can improve outcomes for people with a serious heart valve infection called infective endocarditis. About 30 participants will receive either the phage therapy or a placebo alongside their usual antibiotics. The goal is to see if the combination reduces hospital stays, blood clots, and deaths.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOCARDITIS, BACTERIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Clinical Hospital named after V.V.Vinogradov (branch) of the Peoples' Friendship University of Russia named after Patrice Lumumba
RECRUITINGMoscow, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple dental cleaning prevent a deadly heart infection?
- Heart infection registry aims to unlock better treatments
- One or two infusions could replace weeks of antibiotics for heart infection
- New diagnostic tool could speed up treatment for deadly heart infection
- 22,000 patients studied to unlock secrets of deadly heart infection
- New antibiotic strategy could shorten hospital stays for heart infections